Arena (ARNA) is a Winner For Investors
Arena (ARNA) is a Winner For Investors
Arena (ARNA) is a winner for investors
...and currently at a very attractive price!
Arena's mature, straight forward CEO told us it was going to take time.
Eisai is a capable marketer of pharmaceuticals. It paid Arena a ton of money for the right to sell Belviq in North and most of South America. It will move mountains to get that back and earn a profit. It has a well honed marketing plan. They are educating the Doctors before the TV advertising can begin.
We are hearing better than expected reports on the efficacy of Belviq, albeit from ARNA shareholders so must be tempered some.
Our only close competitor has one hand tied behind its back and is troubled.
Gaining customers for Belviq and repeat orders is an accretive process. In time, the miracle of numbers will be evident
Arena has a promising pipeline, too.
MG
https://stockcharts.com/h-sc/ui?s=ARNA